Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Calumet Specialty Products ( (CLMT) ).
On January 23, 2026, Calumet, Inc. entered into a Ninth Amendment to its Third Amended and Restated Credit Agreement, originally dated February 23, 2018, with its general partner, affiliates, lenders and Bank of America, N.A. as administrative agent, extending the facility’s maturity to January 23, 2031 and setting commitments at $500 million, subject to borrowing base limits. The amendment revises covenants, representations, events of default and other terms to allow Calumet or its subsidiaries to undertake new inventory financing transactions, with commitments under the facility to be reduced from $500 million to $425 million if any such inventory financing is completed, signaling a shift in the company’s capital structure and liquidity management strategy that could affect its future borrowing capacity and funding mix.
The most recent analyst rating on (CLMT) stock is a Hold with a $21.00 price target. To see the full list of analyst forecasts on Calumet Specialty Products stock, see the CLMT Stock Forecast page.
Spark’s Take on CLMT Stock
According to Spark, TipRanks’ AI Analyst, CLMT is a Neutral.
The score is held back mainly by weak financial fundamentals (negative profitability, negative equity, and negative operating/free cash flow). This is partially offset by improving technical trend/momentum, a strong and strategically optimistic earnings call, and a positive debt-maturity extension that lowers near-term refinancing risk, while valuation remains challenged due to losses (negative P/E) and no dividend yield.
To see Spark’s full report on CLMT stock, click here.
More about Calumet Specialty Products
Calumet Specialty Products Partners, L.P. operates in the energy and specialty petroleum products industry, with its operations financed in part through a syndicated credit facility involving Calumet GP, LLC, its subsidiaries, a group of lenders, and Bank of America, N.A. as administrative agent.
Average Trading Volume: 869,900
Technical Sentiment Signal: Buy
Current Market Cap: $1.92B
For detailed information about CLMT stock, go to TipRanks’ Stock Analysis page.